These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 26192751)
21. TAK1 Regulates Myocardial Response to Pathological Stress via NFAT, NFκB, and Bnip3 Pathways. Li L; Chen Y; Li J; Yin H; Guo X; Doan J; Molkentin JD; Liu Q Sci Rep; 2015 Nov; 5():16626. PubMed ID: 26564789 [TBL] [Abstract][Full Text] [Related]
22. Suppression of epithelial restitution using an inhibitor against Rho-associated coiled-coil containing protein kinase aggravates colitis through reduced epithelial expression of A-kinase anchor protein 13. Kangawa Y; Yoshida T; Yonezawa Y; Maruyama K; Hayashi SM; Shibutani M Exp Toxicol Pathol; 2017 Oct; 69(8):557-563. PubMed ID: 28535907 [TBL] [Abstract][Full Text] [Related]
23. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload. Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822 [TBL] [Abstract][Full Text] [Related]
24. Requirement of protein kinase D1 for pathological cardiac remodeling. Fielitz J; Kim MS; Shelton JM; Qi X; Hill JA; Richardson JA; Bassel-Duby R; Olson EN Proc Natl Acad Sci U S A; 2008 Feb; 105(8):3059-63. PubMed ID: 18287012 [TBL] [Abstract][Full Text] [Related]
25. Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling. Malekar P; Hagenmueller M; Anyanwu A; Buss S; Streit MR; Weiss CS; Wolf D; Riffel J; Bauer A; Katus HA; Hardt SE Hypertension; 2010 Apr; 55(4):939-45. PubMed ID: 20177000 [TBL] [Abstract][Full Text] [Related]
26. Mice Deficient in AKAP13 (BRX) Are Osteoporotic and Have Impaired Osteogenesis. Koide H; Holmbeck K; Lui JC; Guo XC; Driggers P; Chu T; Tatsuno I; Quaglieri C; Kino T; Baron J; Young MF; Robey PG; Segars JH J Bone Miner Res; 2015 Oct; 30(10):1887-95. PubMed ID: 25892096 [TBL] [Abstract][Full Text] [Related]
27. The transcriptional coactivator CAMTA2 stimulates cardiac growth by opposing class II histone deacetylases. Song K; Backs J; McAnally J; Qi X; Gerard RD; Richardson JA; Hill JA; Bassel-Duby R; Olson EN Cell; 2006 May; 125(3):453-66. PubMed ID: 16678093 [TBL] [Abstract][Full Text] [Related]
28. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload. Zhou N; Ma B; Stoll S; Hays TT; Qiu H Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247 [TBL] [Abstract][Full Text] [Related]
29. Cardiomyocyte specific overexpression of a 37 amino acid domain of regulator of G protein signalling 2 inhibits cardiac hypertrophy and improves function in response to pressure overload in mice. Lee KN; Lu X; Nguyen C; Feng Q; Chidiac P J Mol Cell Cardiol; 2017 Jul; 108():194-202. PubMed ID: 28641980 [TBL] [Abstract][Full Text] [Related]
30. Promotion and inhibition of cardiac hypertrophy by A-kinase anchor proteins. Blant A; Czubryt MP Can J Physiol Pharmacol; 2012 Sep; 90(9):1161-70. PubMed ID: 22856508 [TBL] [Abstract][Full Text] [Related]
31. Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study. Allen RJ; Porte J; Braybrooke R; Flores C; Fingerlin TE; Oldham JM; Guillen-Guio B; Ma SF; Okamoto T; John AE; Obeidat M; Yang IV; Henry A; Hubbard RB; Navaratnam V; Saini G; Thompson N; Booth HL; Hart SP; Hill MR; Hirani N; Maher TM; McAnulty RJ; Millar AB; Molyneaux PL; Parfrey H; Rassl DM; Whyte MKB; Fahy WA; Marshall RP; Oballa E; Bossé Y; Nickle DC; Sin DD; Timens W; Shrine N; Sayers I; Hall IP; Noth I; Schwartz DA; Tobin MD; Wain LV; Jenkins RG Lancet Respir Med; 2017 Nov; 5(11):869-880. PubMed ID: 29066090 [TBL] [Abstract][Full Text] [Related]
32. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling. Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234 [TBL] [Abstract][Full Text] [Related]
33. Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure. Schiekofer S; Shiojima I; Sato K; Galasso G; Oshima Y; Walsh K Physiol Genomics; 2006 Oct; 27(2):156-70. PubMed ID: 16882883 [TBL] [Abstract][Full Text] [Related]
35. Small heat shock protein 20 (Hsp20) facilitates nuclear import of protein kinase D 1 (PKD1) during cardiac hypertrophy. Sin YY; Martin TP; Wills L; Currie S; Baillie GS Cell Commun Signal; 2015 Mar; 13():16. PubMed ID: 25889640 [TBL] [Abstract][Full Text] [Related]
36. RhoGEF12 controls cardiac remodeling by integrating G protein- and integrin-dependent signaling cascades. Takefuji M; Krüger M; Sivaraj KK; Kaibuchi K; Offermanns S; Wettschureck N J Exp Med; 2013 Apr; 210(4):665-73. PubMed ID: 23530122 [TBL] [Abstract][Full Text] [Related]
37. PKCepsilon-PKD1 signaling complex at Z-discs plays a pivotal role in the cardiac hypertrophy induced by G-protein coupling receptor agonists. Iwata M; Maturana A; Hoshijima M; Tatematsu K; Okajima T; Vandenheede JR; Van Lint J; Tanizawa K; Kuroda S Biochem Biophys Res Commun; 2005 Feb; 327(4):1105-13. PubMed ID: 15652511 [TBL] [Abstract][Full Text] [Related]
38. Phospholipase C epsilon scaffolds to muscle-specific A kinase anchoring protein (mAKAPbeta) and integrates multiple hypertrophic stimuli in cardiac myocytes. Zhang L; Malik S; Kelley GG; Kapiloff MS; Smrcka AV J Biol Chem; 2011 Jul; 286(26):23012-21. PubMed ID: 21550986 [TBL] [Abstract][Full Text] [Related]
39. Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Esposito G; Rapacciuolo A; Naga Prasad SV; Takaoka H; Thomas SA; Koch WJ; Rockman HA Circulation; 2002 Jan; 105(1):85-92. PubMed ID: 11772881 [TBL] [Abstract][Full Text] [Related]
40. Protein kinase D3 is a pivotal activator of pathological cardiac hypertrophy by selectively increasing the expression of hypertrophic transcription factors. Li C; Li J; Cai X; Sun H; Jiao J; Bai T; Zhou XW; Chen X; Gill DL; Tang XD J Biol Chem; 2011 Nov; 286(47):40782-91. PubMed ID: 21971046 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]